DexCom Inc (DXCM)
Interest coverage
Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | ||
---|---|---|---|---|---|---|
Earnings before interest and tax (EBIT) | US$ in thousands | 623,000 | 730,700 | 409,400 | 275,600 | 309,700 |
Interest expense | US$ in thousands | 19,000 | 20,300 | 18,600 | 102,000 | 84,700 |
Interest coverage | 32.79 | 36.00 | 22.01 | 2.70 | 3.66 |
December 31, 2024 calculation
Interest coverage = EBIT ÷ Interest expense
= $623,000K ÷ $19,000K
= 32.79
DexCom Inc's interest coverage ratio has shown fluctuations over the past few years. In December 2020, the interest coverage ratio was 3.66, indicating that the company's operating income was able to cover its interest expenses approximately 3.66 times. However, by December 2021, the ratio decreased to 2.70, suggesting a decrease in the company's ability to cover its interest costs.
The trend reversed significantly in December 2022, with a notable increase in the interest coverage ratio to 22.01, demonstrating a much stronger ability to cover interest expenses. This improvement continued in the following years, as indicated by ratios of 36.00 in December 2023 and 32.79 in December 2024. These ratios suggest a substantial improvement in DexCom Inc's financial health and operational efficiency in managing its interest obligations.
Overall, while the company experienced some variability in its interest coverage ratio in recent years, the significant improvement from 2021 to 2022 and the consistently high ratios from 2022 to 2024 indicate a positive trend in DexCom Inc's ability to comfortably meet its interest payments using its operating income.
Peer comparison
Dec 31, 2024